Project Partners
Print

Hemosoft IT and Training Services, Inc. is a company based in Ankara, Turkey. The title of our Company Hemosoft has been selected in accordance with the vision to specialize in the field of Hematology. We have started our R&D activities in 1999 on Blood Bank Information Management System (HemOnline). Hemosoft's projects are mainly based on inter-disciplinary collaboration. Infectious Diseases Control and Epidemiological Surveillance are our other activity areas in the health and biotech sector. The company's products and services are intended to boost the quality of health services and patient safety. With the know-how we have accumulated over the years, we do possess the capability to present turn-key solutions in structuring of health services and health systems including but not limited to establishment of blood centers, provision of devices, equipment and software. all the companies software, control and hardware projects are being developed under the regulatory authorities demands. Throughout the implementation of Hemosoft's projects the company closely collaborates with over 20 universities and many relevant associations, societies, NGOs, governmental and international organizations. The company has completed the implementation of the ISO 9001: 2000 quality management system and accreditation. The projects realized up to date in the national and international arena have received support from the United Nations, European Commission, Scientific and Technological Research Council of Turkey (TUBITAK) and Technology Development Foundation of Turkey and have been nominated for technology awards of Turkish Industrialists' and Businessmen's Association, Technology and Innovation Funding Programs Directorate and Technology Development Foundation of Turkey. (Click here for more information)

 

Hacettepe University Children’s Hospital is the main referral hospital for children who are in need of BMT for malignant and (particularly) non-malignant inherited disorders that are commonly seen due to the increased incidence of family marriages. More than 50 %of the transplanted patient population consists of inherited diseases (for 26 different diagnoses), including very rare diseases. The majority of the patient population consists of high, and very-risk patients. Due to the lack of mid-level practitioners in the BMT Unit until recently, the nurses have gained significant experience in follow up of transplant related complications, participating in decision-making process as well. They are actively involved in developing institutional protocols in the follow up of patients with a variety of diagnoses.     (Click here for more information)

 

The eScience Institute is a cooperatively operated competence centre for computing, data storage and networking infrastructure, multimedia solutions, applied information technologies and communications systems. The main focus is to support the complete scientific lifecycle, from background research, through simulation and experimental design, to data collection and analysis to publication. The eScience Institute promotes applications and subsequently the development of high-grade, intelligent information and communication technology systems. It initiates and coordinates national and international projects on use of ICT in research area; identifies, develops, accumulates and disseminates collaborative research scenarios; collaborates with universities, corporations, agencies and community-based organizations to design, develop, use and evaluate systems that support the scientific life cycle. (Click here for more information)

 

The University Hospital La Fe is a 1400 bed institution in charge of referrals from an area of around 4 million people and is linked to the Universidad de Velancia for educational activities. The Department of Hematology holds long tradition and expertise in the management of patients with malignant and non-malignant haematological diseases. In particular, the hematopoietic stem cell transplant unit holds a transplant activity of over 100 transplants per year including a similar distribution of autologous, allogeneic HLA-matched sibling and unrelated donor stem cell transplantation.

 

Charles University founded in 1348 is one of the oldest universities in the world and nowadays belongs to the most eminent educational and scientific establishments in the Czech Republic which are recognized in both the European and global context. It is an outstanding cultural institution due to its scientific and pedagogical results and its unique historical tradition. Scientific and research activities form the basis on which the doctoral and master´s programs are based at Charles University. Scientific results of Charles University workplaces measured by the amount of financial means provided to universities in the Czech Republic make approximately one third of this financial means. Charles University stresses international cooperation with prestigious educational and scientific establishments. Charles University has entered into 450 bilateral contracts and 170 international partnerships with foreign universities. (Click here for more information)